Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
28.95
-0.02 (-0.07%)
At close: May 30, 2025, 4:00 PM
28.95
0.00 (0.00%)
After-hours: May 30, 2025, 7:22 PM EDT

Legend Biotech Statistics

Total Valuation

Legend Biotech has a market cap or net worth of $5.34 billion. The enterprise value is $4.69 billion.

Market Cap 5.34B
Enterprise Value 4.69B

Important Dates

The last earnings date was Tuesday, May 13, 2025, before market open.

Earnings Date May 13, 2025
Ex-Dividend Date n/a

Share Statistics

Legend Biotech has 184.29 million shares outstanding. The number of shares has increased by 1.67% in one year.

Current Share Class n/a
Shares Outstanding 184.29M
Shares Change (YoY) +1.67%
Shares Change (QoQ) -8.76%
Owned by Insiders (%) 0.14%
Owned by Institutions (%) 48.02%
Float 81.63M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.29
Forward PS n/a
PB Ratio 5.23
P/TBV Ratio 5.25
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 6.44
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.20, with a Debt / Equity ratio of 0.36.

Current Ratio 5.20
Quick Ratio 5.00
Debt / Equity 0.36
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -11.22

Financial Efficiency

Return on equity (ROE) is -20.00% and return on invested capital (ROIC) is -10.33%.

Return on Equity (ROE) -20.00%
Return on Assets (ROA) -8.77%
Return on Invested Capital (ROIC) -10.33%
Return on Capital Employed (ROCE) -17.23%
Revenue Per Employee $279,150
Profits Per Employee -$83,614
Employee Count 2,609
Asset Turnover 0.43
Inventory Turnover 25.08

Taxes

In the past 12 months, Legend Biotech has paid $20.67 million in taxes.

Income Tax 20.67M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -32.43% in the last 52 weeks. The beta is 0.20, so Legend Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.20
52-Week Price Change -32.43%
50-Day Moving Average 32.21
200-Day Moving Average 39.61
Relative Strength Index (RSI) 39.52
Average Volume (20 Days) 1,774,584

Short Selling Information

Short Interest 7.58M
Short Previous Month 6.74M
Short % of Shares Out 7.90%
Short % of Float n/a
Short Ratio (days to cover) 4.32

Income Statement

In the last 12 months, Legend Biotech had revenue of $728.30 million and -$218.15 million in losses. Loss per share was -$1.19.

Revenue 728.30M
Gross Profit 62.61M
Operating Income -237.93M
Pretax Income -287.07M
Net Income -218.15M
EBITDA -228.34M
EBIT -237.93M
Loss Per Share -$1.19
Full Income Statement

Balance Sheet

The company has $1.01 billion in cash and $362.81 million in debt, giving a net cash position of $642.57 million or $3.49 per share.

Cash & Cash Equivalents 1.01B
Total Debt 362.81M
Net Cash 642.57M
Net Cash Per Share $3.49
Equity (Book Value) 1.02B
Book Value Per Share 5.53
Working Capital 984.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$263.31 million and capital expenditures -$9.86 million, giving a free cash flow of -$273.17 million.

Operating Cash Flow -263.31M
Capital Expenditures -9.86M
Free Cash Flow -273.17M
FCF Per Share -$1.48
Full Cash Flow Statement

Margins

Gross margin is 8.60%, with operating and profit margins of -32.67% and -29.95%.

Gross Margin 8.60%
Operating Margin -32.67%
Pretax Margin -27.11%
Profit Margin -29.95%
EBITDA Margin -31.35%
EBIT Margin -32.67%
FCF Margin n/a

Dividends & Yields

Legend Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.67%
Shareholder Yield -1.67%
Earnings Yield -4.09%
FCF Yield -5.12%
Dividend Details

Analyst Forecast

The average price target for Legend Biotech is $77.09, which is 166.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target $77.09
Price Target Difference 166.29%
Analyst Consensus Strong Buy
Analyst Count 12
Revenue Growth Forecast (5Y) 36.93%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Legend Biotech has an Altman Z-Score of 7.3 and a Piotroski F-Score of 2.

Altman Z-Score 7.3
Piotroski F-Score 2